Pyruvate kinase from Plasmodium falciparum: Structural and kinetic insights into the allosteric mechanism

Biochem Biophys Res Commun. 2020 Nov 12;532(3):370-376. doi: 10.1016/j.bbrc.2020.08.048. Epub 2020 Aug 30.

Abstract

During its intra-erythrocytic growth phase, the malaria parasite Plasmodium falciparum relies heavily on glycolysis for its energy requirements. Pyruvate kinase (PYK) is essential for regulating glycolytic flux and for ATP production, yet the allosteric mechanism of P. falciparum PYK (PfPYK) remains poorly understood. Here we report the first crystal structure of PfPYK in complex with substrate analogues oxalate and the ATP product. Comparisons of PfPYK structures in the active R-state and inactive T-state reveal a 'rock-and-lock' allosteric mechanism regulated by rigid-body rotations of each subunit in the tetramer. Kinetic data and structural analysis indicate glucose 6-phosphate is an activator by increasing the apparent maximal velocity of the enzyme. Intriguingly, the trypanosome drug suramin inhibits PfPYK, which points to glycolysis as a set of potential therapeutic targets against malaria.

Keywords: Allostery; Crystal structures; Kinases; Kinetics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allosteric Regulation
  • Amino Acid Sequence
  • Animals
  • Antimalarials / pharmacology
  • Catalytic Domain
  • Crystallography, X-Ray
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology
  • Glycolysis
  • Humans
  • Kinetics
  • Ligands
  • Malaria, Falciparum / parasitology
  • Models, Molecular
  • Plasmodium falciparum / enzymology*
  • Plasmodium falciparum / genetics
  • Protein Conformation
  • Protozoan Proteins / chemistry*
  • Protozoan Proteins / genetics
  • Protozoan Proteins / metabolism*
  • Pyruvate Kinase / chemistry*
  • Pyruvate Kinase / genetics
  • Pyruvate Kinase / metabolism*
  • Suramin / pharmacology

Substances

  • Antimalarials
  • Enzyme Inhibitors
  • Ligands
  • Protozoan Proteins
  • Suramin
  • Pyruvate Kinase